2026年10月29日 20:23 ET 发布 · 更新于 15 天前 · 2 个来源
Dermatology Biotech Bambusa Raises $168.9 Million in US IPO
bloomberg
·
原始报道
Bambusa Therapeutics Inc., an early-stage biotech focused on dermatology and autoimmune diseases, raised $168.9 million in an upsized US initial public offering that priced at the midpoint of its marketed range.
原文